Abstract:Background & Objective: Congenital brain malformations and neurodevelopmental disorders (NDDs) are common pediatric neurological disorders and result in chronic disability. With the expansion of genetic testing, new etiologies for NDDs are continually uncovered, with as many as one third attributable to single-gene pathogenic variants. While our ability to identify pathogenic variants has continually improved, we have little understanding of the underlying cellular pathophysiology in the nervous system that results from these variants. We therefore integrated phenotypic information from subjects with monogenic diagnoses with two large, single-nucleus RNA-sequencing (snRNAseq) datasets from human cortex across developmental stages in order to investigate cell-specific biases in gene expression associated with distinct neurodevelopmental phenotypes. Methods: Phenotypic data was gathered from 1) a single-institution cohort of 84 neonates with pathogenic single-gene variants referred to Duke Pediatric Genetics, and 2) a cohort of 4,238 patients with neurodevelopmental disorders and pathogenic single-gene variants enrolled in the Deciphering Developmental Disorders (DDD) study. Pathogenic variants were grouped into genesets by neurodevelopmental phenotype and geneset expression across cortical cell subtypes was compared within snRNAseq datasets from 86 human cortex samples spanning the 2nd trimester of gestation to adulthood. Results: We find that pathogenic variants associated with speech/cognitive delay or seizures involve genes that are more highly expressed in cortical excitatory neurons than variants in genes not associated with these phenotypes (Speech/cognitive: p=2.25x10^-7; Seizures: p=7.97x10^-12). A separate set of primarily rare variants associated with speech/cognitive delay or seizures, distinct from those with excitatory neuron expression biases, demonstrated expression biases in microglia. We also found that variants associated with speech/cognitive delay and an excitatory neuron expression bias could be further parsed by the presence or absence of comorbid seizures. Variants associated with speech/cognitive delay without seizures tended to involve calcium regulatory pathways and showed greater expression in extratelencephalic neurons, while those associated with speech/cognitive delay with seizures tended to involve synaptic regulatory machinery and an intratelencephalic neuron expression bias (ANOVA by geneset p<2x10^-16). Conclusions: By combining extensive phenotype datasets from subjects with neurodevelopmental disorders with massive human cortical snRNAseq datasets across developmental stages, we identified cell-specific expression biases for genes in which pathogenic variants are associated with speech/cognitive delay and seizures. The involvement of genes with enriched expression in excitatory neurons or microglia highlights the unique role both cell types play in proper sculpting of the developing brain. Moreover, this information begins to shed light on distinct cortical cell types that are more likely to be impacted by pathogenic variants and that may mediate the symptomatology of resulting neurodevelopmental disorders.

Common genetic variants contribute to risk of rare severe neurodevelopmental disorders

Dissecting the contribution of common variants to risk of rare neurodevelopmental conditions

Genetic modifiers of rare variants in monogenic developmental disorder loci

Substantial role of rare inherited variation in individuals with developmental disorders

The differential effects of common and rare genetic variants on cognitive performance across development

Investigating the role of common cis-regulatory variants in modifying penetrance of putatively damaging, inherited variants in severe neurodevelopmental disorders

A meta-analysis of genetic effects associated with neurodevelopmental disorders and co-occurring conditions

Targeted Sequencing Identifies 91 Neurodevelopmental Disorder Risk Genes with Autism and Developmental Disability Biases

Prevalence and phenotypic impact of rare potentially damaging variants in autism spectrum disorder

Rare penetrant mutations confer severe risk of common diseases

How Rare and Common Risk Variation Jointly Affect Liability for Autism Spectrum Disorder.

Genetic Advances in Neurodevelopmental Disorders

Common genetic variants are associated with increased likelihood of some co-occurring mental health conditions among autistic individuals

Non-coding variants are a rare cause of recessive developmental disorders in trans with coding variants

A Large Data Resource of Genomic Copy Number Variation Across Neurodevelopmental Disorders

Penetrance, variable expressivity and monogenic neurodevelopmental disorders

Pathogenic variants associated with speech/cognitive delay and seizures affect genes with expression biases in excitatory neurons and microglia in developing human cortex

When rare meets common: Treatable genetic diseases are enriched in the general psychiatric population

Networks of Neuronal Genes Affected by Common and Rare Variants in Autism Spectrum Disorders

Federated analysis of autosomal recessive coding variants in 29,745 developmental disorder patients from diverse populations

Genetic modifiers and ascertainment drive variable expressivity of complex disorders